SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #2,095CAS 2区Top JournalReview JournalHybrid

Current Treatment Options in Oncology

Abbreviation (ISO):CURR TREAT OPTION ON
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 1.626•SCImago Rank: #2,095•Identifier (ISSN):1527-2729(Print)/1534-6277(Online)•Articles / Year: 114•Estimated Publication Fee (APC): $3,519 USD
Clarivate IF (2026)Q1
5.8
↑ +1.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
48

48 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
114articles/year
32.45% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5.8)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.8)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.7)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.8)
🔵 Computed
20232.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.3)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.08)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.036)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.9)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.851)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.562)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.

Topics Covered (Recognized by AI)
MedicineInternal medicine97.5%Biology95.5%Genetics89.5%Pathology78.7%Oncology72%Surgery71.1%Cancer69.4%Radiology43.7%Immunology42.8%Chemotherapy41%Chemistry32.1%Biochemistry28.5%Radiation therapy28.2%Bioinformatics27.1%Cancer research26.9%Disease23.7%Clinical trial22.4%Psychology21.1%Intensive care medicine20.1%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,095Scopus Q1SCImago Profile
Scopus Coverage:2000-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.626

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
77

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
5.87

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,519 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,926
3-Year Documents340
Citable Documents338

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

OncologyQ1
Pharmacology (medical)Q1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer US
Publication Language
English
Frequency
Bimonthly
Founding Year
2000
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
67/333Q1
ONCOLOGY
JCISCIE
158/333Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—4116
20254.785319
20243.81101,128
20234.31172,177
20225.081242,550
20215.0361122,415
20203.91073,934
20193.851914,048
20183.562813,099
2017—753,420
2016—632,335
2015—602,233
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Current Treatment Options in Oncology

WoS Q1
2356201820192020202120222023202420254.70
Annual Impact Factor Metric
2025:4.7

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: fa3ad0e8-668e-4f06-bb85-89fb46aabb7d
Database Updated: 2026-10-01